Lung Cancer

EA5231 / CLEAR

A Randomized Phase III Trial of Checkpoint Blockade in Lung CancEr Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

Physician Fact Sheet
Schema, eligibility criteria, and treatment details


Patient Educational Material

Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material.

Study Summary for Patients
Study objectives, eligibility criteria, and a simplified schema in lay language to provide a more visual description of the trial to patients. All site staff are encouraged to share this as appropriate when explaining the trial to potential participants.
EA5231 / CLEAR Educational Materials
Clinical Trial Home Page
View EA5231 Record on ClinicalTrials.gov
Review Other Active Trials
ECOG-ACRIN Cancer Research Group